TO INNOVATIONS

ORAL ABSTRACT SESSIONS THURSDAY 27 OCTOBER 2016
14.20 [OA-345-27]
Improved tuberculosis case detection in Afghanistan: an evaluation of passive and active approaches
A Nasrat, A Sanaie, C Mergenthaler, M K Seddiq, S D Mahmoodi, R H Stevens, J Creswell (Afghanistan, Switzerland, United Kingdom)
14.30 [OA-346-27]
The implications of gender on the uptake of isoniazid preventive therapy in Zulu communities of uMgungundlovu District, South Africa
J Boffa, M Mayan, S Ndlovu, R L Cowie, R S Sauve, T Williamson, D Fisher (South Africa, Canada)
14.40 [OA-347-27]
Influence of quality of work life on motivation and retention of local government tuberculosis control programme supervisors
in southeast Nigeria
D Ogbuabor, J Chukwu, I Okoronkwo, O Ossai (Nigeria)
ORAL ABSTRACT SESSION 07 3 15:15-16:45 3 SESSION ROOM 3B
TB MORTALITY
Co-chairs: Derek Sloan (United Kingdom), Mohammed Lamorde (Uganda) – Section: Tuberculosis
15.15 [OA-348-27]
Negative tuberculin skin test result in patients with active TB is associated with increased mortality risk during TB treatment
A Salindri, R-M Sales, S Auld, N Gandhi, M Magee (United States of America)
15.25 [OA-349-27]
Interferon-gamma release assay is associated with disease site and death in active TB
S C Auld, S H Lee, E S Click, R Miramontes, C L Day, N R Gandhi, C M Heilig (United States of America)
15.35 [OA-350-27]
Predictors of mortality among patients registered for TB treatment in Kampala City, Uganda
D Kimuli, D Okello, E Mabumba, D Lukoye, A Etwom, D Sama, N Persaud, S Pedro (Uganda, United States of America)
15.45 [OA-351-27]
Exploring gender differences in treatment outcomes among TB patients in Afghanistan: a cross-sectional study
G Q Qader, A Momand, M K Seddiq, M K Rashidi, S D Mahmoodi, A B Maseed, N Persaud, P G Suarez (Afghanistan, United States of America)
15.55 [OA-352-27]
Spatial distribution profile of mortality due to tuberculosis in an endemic city in the Brazilian Northeast
A A R Queiroz, M C C Garcia, T Z Berra, A S Belchior, L H Arroyo, M A M Arcoverde, F Chiaravalloti Neto, R A Arcêncio (Brazil)
16.05 [OA-353-27]
Challenges to accurately estimate TB mortality: deaths in notified TB cases vs. TB deaths in vital registration system in England
M K Lalor, T Mohiyuddin, T Uddin, H L Thomas (United Kingdom)
16.15 [OA-354-27]
Influenza pandemics and TB mortality in the 19th and 20th century in Switzerland
K Zürcher, M Zwahlen, M Ballif, M Egger, L Fenner (Switzerland)
16.25 [OA-355-27]
Associations of influenza vaccination with incident tuberculosis and all-cause mortality among elderly Taiwanese patients
Y-F Yen, W-J Su (Taiwan)
ORAL ABSTRACT SESSION 08 3 15:15-16:45 3 SESSION ROOM 1C
“THE LONG AND WINDING ROAD”: LATENT TB INFECTION TESTING AND TREATMENT
Co-chairs: Anete Trajman (Brazil), Gavin Churchyard (United Kingdom) – Section: Tuberculosis
15.15 [OA-356-27]
The global burden of latent tuberculosis infection
R M G J Houben, P J Dodd (United Kingdom)
15.25 [OA-357-27]
Diagnostic accuracy of a novel C-Tb skin test for LTBI: results from two Phase III trials
M Ruhwald, J Cayla, H Aggerbeck, K Dheda, P Andersen (Denmark, Spain, South Africa)
15.35 [OA-358-27]
Performance of screening tests for latent tuberculosis in young, foreign-born children using latent class analysis
J Stout, Y Wu, S Ghosh, M Whipple, M Johnson, A Pettit, C Ho, Tuberculosis Epidemiologic Studies Consortium (United States of America)
15.45 [OA-359-27]
National roll-out of latent tuberculosis testing and treatment for new migrants in England: retrospective evaluation in high TB incidence area
M Loutet, M Burman, D Trathen, H Kunst, D Zenner (United Kingdom)
74 CONFRONTING RESISTANCE: FUNDAMENTALS TO INNOVATION - THE 47 TH UNION WORLD CONFERENCE ON LUNG HEALTH